GLP-1 medicines and menopause
Two big changes, often in the same years.
Many women start a GLP-1 medicine just as their hormones are changing. Here’s what the medicines do, where the two overlap, and what’s worth asking.
Reviewed by the Kenning clinical and outcomes research team · Updated November 2026
1 in 5
US women aged 50 to 64 have used a GLP-1 medicine, more than any other age and sex group.
RAND survey of 8,793 Americans, 2025
What GLP-1 medicines do
They act on the conversation between your gut and your brain. Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are the best known.
Copy a gut hormone
Your gut releases GLP-1 after you eat. These medicines act on the same receptors, for much longer.
Help control blood sugar
They help the pancreas release insulin when blood sugar is high.
Slow the stomach
Food leaves the stomach more slowly, so you feel full sooner. This effect often lessens with time.
Quiet appetite signals
They act on appetite areas in the brain. Many people describe quieter “food noise.”
Tirzepatide also acts on a second gut hormone, GIP. Read the evidence Read the evidence
middot; Compare semaglutide and tirzepatideYour decision map
Not stages of menopause. The four decisions you’ll face with a GLP-1 medicine, and what changes for you at each one.
Considering
Is it right for me, now?
Check your numbers on two rulers
Hong Kong calls a BMI of 23 overweight. Many medicine labels start at 27 or 30.
Mirror Four checkAsk who was studied
About 13% of people in the main semaglutide trial were Asian.
The East Asian trialHot flashes or poor sleep too?
Ask about menopause care alongside any weight medicine.
Hot flash treatments“Not yet” is a real answer
Sometimes the honest answer is a referral and a plan instead.
Rose’s story
Starting
The first three months
Side effects peak as the dose goes up
Most are mild to moderate. You can ask to go slower.
See the numbersOn tirzepatide and the pill?
Use a non-oral method or a barrier for 4 weeks after starting and after each dose increase.
Manufacturer guidanceEat enough protein from day one
Losing weight fast makes protein matter more.
Find your protein rangePhotograph your hair part
Same spot, same light. It’s a better guide than the drain.
Hana’s story
Staying on
Month three and beyond
Shedding two to three months in?
Fast weight loss is usually part of it. It often settles.
Hair loss evidenceMedicine, menopause or something else?
Sort your symptoms before your next appointment.
Sort your symptomsProtect muscle and bone
Lean tissue falls along with fat. Strength training helps.
Strength and boneHormone therapy may play a part
Early studies found more weight loss. They can’t prove cause.
Read the evidence
Stopping
Before, during and after
Plan before you stop
Most people regain part of the weight. That’s a reason to plan, not a failure.
What happensKeep measuring your Mirror Four
Watch the direction over months, not the scale each day.
Mirror Four checkMenopause doesn’t stop with the medicine
Night sweats and poor sleep may still need care.
Bee’s storyMake a stopping plan
Questions to settle with your prescriber first.
Stopping plan
Perimenopause: periods changing. After menopause: no period for 12 months. Not sure? Choose “Show all.”
Is it the medicine, or menopause?
Some symptoms point one way. Many could be either, or both, or something else entirely.
More often menopause
- Hot flashes
- Night sweats
- Vaginal dryness
- Changing periods
Could be either
- Tiredness
- Poor sleep
- Mood changes
- Hair shedding
- Muscle loss
- Brain fog
More often the medicine
- Nausea
- Constipation or diarrhea
- Reflux
- Feeling full fast
Timing is a clue. Stomach side effects are most common while the dose is going up. See the numbers
It’s a guide, not a diagnosis. Thyroid problems, low iron, poor sleep and other medicines can cause the same feelings. A good clinician checks those too.
Women who’ve been here
From our book, The Mirror and the Medicine.
Questions to take to your appointment
Adapted from the questions the women in our book took to their own doctors.
- Am I an appropriate candidate, and for what condition?
- Can we go slower if the side effects are hard?
- Could my night sweats or poor sleep be menopause, and who should I see?
- What should we track besides weight, such as muscle, bone and blood tests?
- What is our plan if I stop?
- Am I a candidate for hormone therapy, and what are my personal risks?
Doctor visit kit
Put your symptoms, questions and history on one page before your appointment.
Start+ Sources for this page
- Bozick R, et al. New Weight Loss Drugs: GLP-1 Agonist Use and Side Effects in the United States. RAND Corporation, 2025.
- Wegovy (semaglutide) prescribing information, DailyMed.
- Wilding JPH, et al. STEP 1. New England Journal of Medicine, 2021.
- Kadowaki T, et al. STEP 6. Lancet Diabetes & Endocrinology, 2022.
- Watson SL, et al. LIFTMOR. Journal of Bone and Mineral Research, 2018.
- Hurtado MD, et al. Semaglutide and hormone therapy. Menopause, 2024.
- Mayo Clinic News Network. Hormone therapy and tirzepatide, 2026.
- Lilly Medical. Zepbound and oral contraceptives.
- Rodriguez PJ, et al. GLP-1 discontinuation and reinitiation. JAMA Network Open, 2025.
- Wilding JPH, et al. STEP 1 extension. Diabetes, Obesity and Metabolism, 2022.
- Centre for Health Protection, Hong Kong. Obesity, 2018.
More answers, with sources and evidence ratings, in our Evidence library. Kenning provides education, not medical advice. Talk with your healthcare provider before starting, stopping or changing any medicine.
Make sense of what’s changing.
Free tools, plain answers and Bestie, Is This True?, our newsletter, every two weeks.